Predictive Value of FDG-PET in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.117.199778
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

The Predictive Value of 18f-FDG-Pet Early Evaluation in Patients With Metastatic Gastric Adenocarcinoma Treated With Chemotherapy Plus Cetuximab

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2007English

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

Prognostic Value of FDG PET Imaging in Patients With Laryngeal Cancer

PLoS ONE
Multidisciplinary
2014English

The Value of FDG-PET in Patients With Painful Total Knee Arthroplasty

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2006English

Vandetanib Experience in a Patient With Ectopic Cushing Syndrome in Metastatic Medullary Thyroid Cancer

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma

Oncology
MedicineCancer ResearchOncology
2016English

Predictive Potential of FDG-PET/CT for Histological Transformation in Patients With Indolent Lymphoma

Advances in Molecular Imaging
2014English

A Case of Postoperative Liver Metastasis From Medullary Carcinoma of Thyroid Treated With Chemoembolization

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy